Current progress of genetically engineered pig models for biomedical research

BioResearch Open Access

Volumn 3, Issue 6, 2014, Pages 255-264

  Gün, Gökhan ^a,b,c   Kues, Wilfried A ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

binary transposon; disease model; domestic animal; humanized pig; large animal model; programmable nuclease

Indexed keywords

NUCLEASE; RECOMBINASE;

AGING; BIOACCUMULATION; CANCER MODEL; CARDIOVASCULAR DISEASE; CYSTIC FIBROSIS; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA MODIFICATION; GENE SEQUENCE; GENETIC ENGINEERING; GENOME ANALYSIS; HUMAN; IMMUNOLOGY; MEDICAL RESEARCH; NONHUMAN; OPHTHALMOLOGY; PATHOPHYSIOLOGY; PORCINE MODEL; REVIEW; SWINE; TRANSGENIC ORGANISM; TRANSGENIC PIG; TRANSGENICS; TRANSPOSON; XENOTRANSPLANTATION;

ANIMALIA; SUIDAE;

EID: 84926321082     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2014.0039     Document Type: Review

References (100)

1. Clark J, Whitelaw B. A future for transgenic livestock. Nat Rev Genet. 2003;4:825-833
2. Robl JM, Wang Z, Kasinathan P, Kuroiwa Y. Transgenic animal production and animal biotechnology. Theriogenology. 2007;67:127-133
3. Whyte JJ, Prather RS. Genetic modifications of pigs for medicine and agriculture. Mol Reprod Dev. 2011;78: 879-791
4. GarrelsW, Ivics Z, KuesWA. Precision genetic engineering in large mammals. Trends Biotechnol. 2012;7:386-393
5. Hall VJ. Early development of the porcine embryo: the importance of cell signalling in development of pluripotent cell lines. Reprod Fertil Dev. 2012;25:94-102
6. Nowak-Imialek M, Niemann H. Pluripotent cells in farm animals: state of the art and future perspectives. Reprod Fertil Dev. 2012;25:103-128
7. Esteban MA, Xu J, Jang J, et al. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem. 2011;284:17634-17640
8. Ezashi T, Telugu B, Alexenko AP, et al. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci USA. 2011;106:10993-10998
9. Wu Z, Chen J, Ren J, et al. Generation of pig-induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol. 2011;1:46-54
10. Kues WA, Herrmann D, Barg-Kues B, et al. Derivation and characterization of sleeping beauty transposon-mediated porcine induced pluripotent stem cells. Stem Cells Dev. 2013;22:124-135
11. West FD, Terlouw SL, Kwon DJ, et al. Porcine induced pluripotent stem cells produce chimeric offspring. Stem Cells Dev. 2011;19:1211-1220
12. Fan N, Chen J, Shang, et al. Piglets cloned from induced pluripotent stem cells. Cell Res. 2013;23:162-166
13. Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014;15: 321-334
14. Prather RS, Lorson M, Ross JW. Genetically engineered pig models for human diseases. Annu Rev Anim Biosci. 2013;1:203-219
15. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J. 2004;23:146-158
16. Veit G, Bossard F, Goepp J, et al. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol Biol Cell. 2012;23:4188-4202
17. Du K, Lukacs GL. Cooperative assembly and misfolding of CFTR domains in vivo. Mol Biol Cell. 2009;20:1903-1915
18. Bragonzi A. Murine models of acute and chronic lung infection with cystic fibrosis pathogens. Int J Med Microbiol. 2010;300:584-593
19. Rogers CS, Stoltz DA, Meyerholz DK, et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science. 2008;321:1837-1841
20. Rogers CS, Hao Y, Rokhlina T, et al. Production of CFTR null and DF508 heterozygous pigs by AAV-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest. 2008;118:1571-1577
21. Ostedgaard LS, Meyerholz DK, Chen JH, et al. The DF508 mutation causes CFTR misprocessing and cystic fibrosislike disease in pigs. Sci Transl Med. 2011;3:74ra24
22. Cheon D-J, Orsulic S. Mouse models of cancer. Annu Rev Pathol. 2011;6:95-119
23. Flisikowska T, Merkl C, Landmann M, et al. A porcine model of familial adenomatous polyposis. Gastroenterology 2012;143:1173-1175
24. Leuchs S, Saalfrank A, Merkl C, et al. Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS ONE. 2012;7:e43323
25. Sieren JC, Meyerholz DK, Wang XJ, et al. Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Invest. 2014;124:4052-4066
26. Luo Y, Li J, Liu Y, et al. High efficiency of BRCA knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer. Transgenic Res. 2011;20:975-988
27. Deng CX, Wang RH. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet. 2003;12:113R-123R.
28. Turk JR, Laughlin MH. Physical activity and atherosclerosis: which animal model?. Can J Appl Physiol. 2004;29: 657-683
29. Al-Mashhadi RH, Sørensen CB, Kragh PM, et al. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med. 2013;5:166ra1
30. Saeki K, Matsumoto K, Kinoshita M, et al. Functional expression of a Delta12fatty acid desaturase gene from spinach in transgenic pigs. Proc Natl Acad Sci USA. 2004;101: 6361-6366
31. Hao YH, Yong HY, Murphy CN, et al. Production of endothelial nitric oxide synthase (eNOS) over-expressing piglets. Transgenic Res. 2006;15:739-750
32. Thomas SR, Chen K, Keaney JF Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem. 2002;277:6017-6024
33. Whyte JJ, Samuel M, Mahan E, et al. Vascular endothelium-specific overexpression of human catalase in cloned pigs. Transgenic Res. 2011;20:989-1001
34. Nicholls SJ, Uno K. Peroxisome proliferator-Activated receptor (PPARa/g) agonists as a potential target to reduce cardiovascular risk in diabetes. Diabetes Vasc. Dis. Res. 2012;9:89-94
35. Yang D, Yang H, Li W, et al. 2011. Generation of PPARc mono-Allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Res. 2011;21:979-982
36. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36: S67-S74
37. Renner S, Fehlings C, Herbach N, et al. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes. 2010;59:1228-1238
38. Nyunt O, Wu JY, McGown IN, et al. Investigating maturity onset diabetes of the young. Clin Biochem Rev. 2009; 30:67-74
39. Umeyama K, Watanabe M, Saito H, et al. 2009. Dominantnegative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs. Transgenic Res. 2009; 18:697-706
40. Støy J, Steiner DF, Park S-Y, et al. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord. 2010;11:205-215
41. Renner S, Braun-Reichhart C, Blutke A, et al. Permanent neonatal diabetes in INS(C94Y) transgenic pigs. Diabetes. 2013;62:1505-1511
42. Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;6:1204-1222
43. Walsh DM, Klyubin I, Shankar GM, et al. The role of cellderived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem Soc Trans. 2005;33:1087-1090
44. Kragh PM, Nielsen AL, Li J, et al. 2009. Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw. Transgenic Res. 2009;18:545-558
45. Sondergaard LV, Ladewig J, Dagnaes-Hansen F, et al. Object recognition as a measure of memory in 1-2 years old transgenic minipigs carrying the APPsw mutation for Alzheimer's disease. Transgenic Res. 2012;21:1341-1348
46. Jakobsen JE, Johansen MG, Schmidt M, et al. Generation of minipigs with targeted transgene insertion by recombinasemediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT). Transgenic Res. 2013;22:709-723
47. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407:802-809
48. Rubinsztein DC, Carmichael J. Huntington's disease: molecular basis of neurodegeneration. Expert Rev Mol Med. 2003;5:1-21
49. Yang D, Wang CE, Zhao B, et al. Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet. 2010; 19:3983-3994
50. Baxa M, Hruska-Plochan M, Juhas S, et al. A transgenic minipig model of Huntington's disease. J Huntingtons Dis 2013;2:47-68
51. Chandler MJ, Smith PJ, Samuelson DA, et al. Photoreceptor density of the domestic pig retina. Vet Ophthalmol. 1999;2:179-184
52. Gerke CG, Hao Y, Wong F. Topography of rods and cones in the retina of the domestic pig. Hong Kong Med J. 1995;1:302-308
53. Petters RM, Alexander CA, Wells KD, et al. Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol. 1997;15:965-970
54. Ross JW, Fernandez De Castro JP, Zhao J, et al. Generation of an inbred miniature pig model of retinitis pigmentosa. Investig Ophthalmol Vis Sci. 2012;53:501-507
55. Fernandez De Castro JP, Scott PA, James W, et al. Cone photoreceptors develop normally in the absence of functional rod photoreceptors in a transgenic swine model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;55: 2460-2468
56. Scott PA, Fernandez De Castro JP, Kaplan HJ, et al. A Pro23His mutation alters prenatal rod photoreceptor morphology in a transgenic swine model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;28:2452-2459
57. Kitiratschky VB, Wilke R, Renner AB, et al. Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration. Invest Ophthalmol Vis Sci. 2008;49:5015-5023
58. Kelsell RE, Gregory-Evans K, Payne AM, et al. Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet. 1998;7:1179-1184
59. Kostic C, Lillico SG, Crippa SV, et al. Rapid cohort generation and analysis of disease spectrum of large animal model of cone dystrophy. PLoS ONE. 2013;8:e71363
60. Sommer JR, Estrada JL, Collins EB, et al. Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Br J Ophthalmol. 2011; 95:1749-1754
61. Suzuki S, Iwamoto M, Saito Y, et al. Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell. 2012;10:753-758
62. Belizário JE. Immunodeficient mouse models: an overview. Open Immunol J. 2009;2:79-85
63. Burg M, Gennery AR. Educational paper: the expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr. 2011;170:561-571
64. Watanabe M, Nakano K, Matsunari H, et al. Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nucleaseencoding mRNA. PLoS ONE. 2013;8:e76478
65. Huang J, Guo X, Fan N, et al. RAG1/2 Knockout pigs with severe combined immunodeficiency. J Immunol. 2014; 193:1496-1503
66. Lee K, Kwon DN, Ezashi T, et al. Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci USA. 2014;111: 7260-7265
67. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol. 2007; 7:519-531
68. Klymiuk N, Aigner B, Brem G, et al. Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev. 2010;77:209-221
69. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005;83:674-686
70. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med. 2005;11: 29-31
71. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of a1, 3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med. 2005;11:32-34
72. Lutz AJ, Li P, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose a-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation. 2013;20:27-35
73. Iwase H, Ekser B, Hara H, et al. Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition. Xenotransplantation. 2014;21:72-83
74. Bongoni AK, Kiermeir D, Jenni H, et al. Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood. Xenotransplantation. 2014;21: 230-243
75. Burdorf L, Stoddard T, Zhang T, et al. Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury. Am J Transplant. 2014;14: 1084-1095
76. Bottino R, Wijkstrom M, Van der Windt DJ, et al. Pig-tomonkey islet xenotransplantation using multi-transgenic pigs. Am J Transplant. 2014;14:2275-2287
77. Switzer W, Michler M, Shanmugam RE, et al. Lack of cross-species transmission of porcine endogenousretrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation. 2001;71:959-965
78. Irgang M, Sauer IM, Karlas A, et al. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol. 2003;28:141-154
79. Dieckhoff B, Petersen B, Kues WA, et al. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation. 2008;15:36-45
80. Ramsoondar J, Vaught T, Ball S, et al. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation. 2009;16: 164-180
81. Chung HC, Nguyen VG, Kim HJ, et al. Inhibition of porcine endogenous retrovirus in PK15 cell line by efficient multitargeting RNA interference. Transpl Int. 2014;27: 96-105
82. Li ZG, Lie GB, Pan MX, et al. Knockdown of porcine endogenous retroviruses by RNA interference in chinese experimental miniature pig fibroblasts. Transplant Proc. 2013;45:748-755
83. Yamada K, Tasaki M, Sekijima M, et al. Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model. Transplantation. 2014;98:411-418
84. Sekijima M, Waki S, Sahara H, et al. Results of lifesupporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout swine. Transplantation. 2014; 98:419-426
85. Garrels W, Mates L, Holler, S., et al. Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PLoS ONE 2011;6:e23573
86. Ivics Z, Garrels W, Mátés L, et al. Germline transgenesis in pigs by cytoplasmic microinjection of Sleeping Beauty transposons. Nat Protoc. 2014;9:810-827
87. Garrels W, Holler S, Taylor U, et al. 2011. Genotypeindependent transmission of transgenic fluorophore protein by boar spermatozoa. PLoS ONE. 2011;6:e27563
88. Garrels W, Holler S, Cleve N, et al. Assessment of fecundity and germ line transmission in two transgenic pig lines produced by sleeping beauty transposition. Genes (Basel). 2012 3 615-633
89. Garrels W, Holler S, Taylor U, et al. Assessment of fetal cell chimerism in transgenic pig lines generated by sleeping beauty transposition. PLoS ONE. 2014;9:e96673
90. Whyte JJ, Zhao J, Wells KD, et al. Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs. Mol Reprod Dev. 2011;78:2
91. Hauschild J, Petersen B, Santiago Y, et al. generation of a biallelic knockout in pigs using zinc-finger-nucleases. Proc Natl Acad Sci USA. 2011;108:12013-12017
92. Hai T, Teng F, Guo R, et al. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res. 2014;24:372-375
93. Kaneko N, Itoh K, Sugiyama A, Izumi Y. Microminipig, a non-rodent experimental animal optimized for life science research: preface. J Pharmacol Sci. 2011;115: 112-114
94. Kwon DN, Lee K, Kang MJ, et al. Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs. Sci Rep. 2013; 3:1981
95. Klose R, Kemter E, Bedke T, et al. Expression of biologically active human TRAIL in transgenic pigs. Transplantation. 2005;80:222-230
96. Weiss EH, Lilienfeld BG, Müller S, et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation. 2009;87:35-43
97. Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation. 2009;16:522-534
98. Stoltz DA, Rokhlina T, Ernst SE, et al. Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J Clin Invest. 2013;123:2685-2693
99. Ramsoondar J, Mendicino M, Phelps C, et al. Targeted disruption of the porcine immunoglobulin kappa light chain locus. Transgenic Res. 2011;20:643-653
100. Mendicino M, Ramsoondar J, Phelps C, et al. Generation of antibody- and B cell-deficient pigs by targeted disruption of the J-region gene segment of the heavy chain locus. Transgenic Res. 2011;20:625-641